1
Department of Intensive Care, Maastricht University Medical Centre+, Maastricht, Netherlands
2
Department of Medical Intensive Care, Hamad Medical Corporation, Doha, Qatar
3
Department of Anaesthesiology, ICU and Perioperative Medicine, Hamad Medical Corporation, Doha, Qatar
Abstract
Since the last decade extracorporeal membrane oxygenation (ECMO) therapy has been widely accepted as the treatment of life-threatening cardiac and pulmonary failure. Maintaining homeostasis of the haemostatic system remains a major challenge. The choice of anticoagulants to inhibit continuous activation of coagulation by the non-endothelialised systems is still restricted. The most widely used agent is intravenous unfractionated heparin. Although one might expect monitoring of the anticoagulant level to be straightforward, the number of bleeding or thrombotic complications is still too high. In this review, we report the impact of an extracorporeal circuit on the coagulation system and its complications. We describe the strategies for anticoagulation and possibilities of monitoring their effects. Finally, we give a view of the future developments in this specific field. © 2018 NVIC. All rights reserved.
License
Copyright (c) Netharland Journal of Critical Care
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Neth. J. Crit. Care open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.